An open-label phase 2 study of the efficacy and safety of glufosfamide in previously treated advanced soft tissue sarcoma.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2015
At a glance
- Drugs Glufosfamide (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Sponsors Eleison Pharmaceuticals
- 12 May 2009 Actual end date (1 Oct 2008) added as reported by ClinicalTrials.gov.
- 18 Jan 2008 Results have been reported in a Threshold Pharmaceuticals media release.
- 05 Dec 2007 Status changed from recruiting to completed.